“Dupilumab Improves Symptoms and Quality of Life in Pediatric Patients With Moderate-to-Severe Atopic Dermatitis in Clinical Practice: RELIEVE-AD-PED Study”. SKIN The Journal of Cutaneous Medicine 10, no. 2 (March 10, 2026): s737. Accessed April 29, 2026. https://skin.dermsquared.com/skin/article/view/4059.